Submission requirements for Innovations in Clinical Neuroscience (Online ISSN 2158-8341, Print ISSN 2158-8333) are in accordance with the International Committee of Medical Journal Editors (ICMJE). See Uniform Requirements for Manuscripts Submitted to Biomedical Journals.
Innovations in Clinical Neuroscience (ICNS) is a peer-reviewed electronic-only journal (www.innovationscns.com) for healthcare clinicians and researchers in the field of neuroscience. Psychiatry is a core focus of ICNS; however, neurology, pain, Alzheimer’s/dementia, other CNS-related fields are covered in the journal as well. In addition to providing information relevant to patient treatment in these fields, we also cover a unique and interesting area of neuroscience: drug development and trial methodology. We strive to present all evidence-based information in a straightforward, “how-to” fashion for not only the practicing clinician but for the investigator involved in drug development.
SCOPE OF MANUSCRIPTS
Manuscripts that meet our editorial purpose include but are not limited to: (1) reports of preclinical and clinical research studies that expand existing knowledge; (2) case studies and reports that stimulate research and the exchange of information; (3) in-depth reviews of clinical practice, management, reimbursement, education, ethics, and legal issues; (4) reviews and reports of contemporary topics in neuroscience that may affect the delivery, reimbursement, or practice of psychiatry, neurology, or related fields of neuroscience.
Original Research. Reports of investigations that address questions about clinical care or trial methodology or expand existing knowledge. References and illustrative material are recommended. Must include abstract. Recommended length: up to 6000 words, not including references.
Review Articles. Comprehensive articles summarizing the latest evidence-based strategies to facilitate the clinician’s approach to diagnosis and treatment of a particular disorder or disease; articles highlighting emerging or unique diagnostic and therapeutic modalities; or articles seeking to improve upon existing drug trial methodology or highlight or summarize new and effective trial methodology. May also include in-depth reviews of clinical practice, management, reimbursement, educational, ethical, and legal issues. At least 25 current references are recommended. Illustrative material is preferred. Must include abstract. Recommended length: up to 6000 words, not including references.
Case Reports. Short presentations of actual cases that stimulate research and the exchange of information and illustrate the signs and symptoms, diagnosis, and treatment of a disorder. At least 15 current references are recommended. Illustrative material is preferred. Must include abstract. Recommended length 1000 to 3000 words, not including references.
Brief Reports. Short reports of original studies or evaluations or unique, first-time reports of clinical case series. Must include abstract. Recommended length: 1000 to 1500 words (not including references).
Commentaries. Essays that address important topics in neuroscience and generally are not linked to a specific article. Commentaries should be well focused, scholarly, and clearly presented. Include approximately 20 references. Recommended length: 1500 to 2000 words.
Letters to the Editor. Opinions on cases or articles published in Innovations in Clinical Neuroscience, opinions on other current topics, or short reports of clinical interest. Must be concise and to the point. Please indicate whether the letter is intended for publication. Text should not exceed 600 words, with no more than five references. Letters should be received within two months of the article’s publication and may be sent to the original author for reply. The editor reserves the right to edit the material for style, clarity, and size.
Submissions for consideration may be sent electronically to: Elizabeth Klumpp, Executive Editor, eklumpp (at) matrixmedcom (dot) com. Hard copy submissions are no longer accepted.
Cover Letter. Manuscripts should be submitted with a cover letter indicating the article type. The cover letter should give details on any previous or duplicate publication of any of the content and should state that the paper is not under consideration for publication elsewhere. In the cover letter, authors should disclose any potential financial conflicts of interest relevant to the submitted manuscript. For Letters to the Editor, please indicate whether the letter is intended for publication.
Conflict of Interest Disclosures. All authors should disclose any potential financial conflicts of interest relevant to the submitted manuscript in the cover letter of the submitted manuscript.
Author and Copyright Forms. Upon submission, authors will be asked to complete and return an Author Form, which requires corresponding author information, authorship statement, and financial disclosure. Authors will also be asked to sign and return a copyright form. If the manuscript is accepted and published in Innovations in Clinical Neuroscience, authors must transfer copyright to Matrix Medical Communications.
Registration of Clinical Trials. As recommended by the ICMJE, Innovations in Clinical Neuroscience requires as a condition of consideration for publication, registration of all clinical trials in a public trials registry that requires the minimum registration data set as determined by the ICMJE [visit http://www.icmje.org/index.html#clin_trials for guidelines]. Please include the trial registry name, registration number, and the url for the registry in the abstract.
Inclusion of previously published materials. Any material submitted to Innovations in Clinical Neuroscience that is reproduced from previously published copyrighted material must be accompanied by a letter of permission from the copyright holder. All such material should include a full credit line (e.g., in the figure or table legend) acknowledging the original source. The author is responsible for obtaining the permission and is responsible for any associated fees.
Title Page. The title page should contain the following elements: title, author names and institutional affiliations, sources of financial support, name of corresponding author with his or her complete contact information (mailing address, telephone and fax numbers, e-mail address), and word count (text only).
Spacing and Pagination. The manuscript should be typed using double spacing throughout. Do not use a running head. Pages should be numbered beginning with the title page. Manuscripts should NOT contain any automatic formatting, except for the page number at the top right corner of each page.
Abstract. Include a structured abstract with all articles, except letters to the editors. Abstracts should be limited to 250 words and should be organized into the following categories: Objective, Design, Setting, Participants, Measurements, Results, Conclusion. Abstracts of clinical trials must include trial registry information (registry name, registration number, and url for the registry).
Keywords. Include all relevant keywords following the abstract.
Abbreviations/Acronyms. All abbreviations and acronyms should be spelled out at first mention.
References. Citation accuracy is the responsibility of the author. Requirements are in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals. References must be cited in text in numerical order and must appear as a complete list at the end of the manuscript. (See Uniform Requirements.) Do not superscript reference numbers in the text; place the numbers at the end of the corresponding sentences or paragraphs between brackets. Abbreviate names of journals according to Index Medicus style. Book references should include the author(s), editor(s), title, edition number, publisher and city, copyright date, volume, and specific page numbers for quoted material.
The sequence for a journal article should be: authors (up to four; for five or more authors, list the first three, followed by et al), title of paper, journal name abbreviated as in the Index Medicus, year of publication, volume number, issue number and first and last page numbers. Example:
1. Stark D, Kiely M, Smith A, et al. Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol. 2002;20:3137–3148.
The sequence for chapters of a book should be: author(s), chapter title, editors, book title, edition, place of publication, publisher, year, page numbers. Example:
2. Holland JC, Gooen-Piels J. Principles of psycho-oncology. In: Holland JC, Frei E (eds). Cancer Medicine, Fifth Edition. Hamilton (Ontario): Decker;2000:943–958.
The sequence for conference proceedings is:
3. Heller T. Promoting healthy aging and community inclusion of adults with developmental disabilities. Presented at the National Association for the Dually Diagnosed; 2003 Oct 24; Chicago.
Authors are responsible for ensuring that the list contains all references cited in the text, in order, accurately.
Tables and Figures. All illustrative material must be numbered consecutively according to citation in text. If a figure or table has been previously published, the complete reference information must be cited, and written permission from the publisher to reproduce must be submitted with the material. Obtaining permission (and any associated fees) to include previously published materials in a Innovations in Clinical Neuroscience submission is the responsibility of the author. Photographic illustrations may be submitted as color or black-and-white electronic .jpg or .tif files (min. 300 dpi). Other types of illustrations (e.g., drawings, graphs, charts) must be professionally executed and also submitted electronically. Symbols and abbreviations should be defined/spelled out. For black-and-white or color photographs, the required resolution is at least 300 dpi. For line drawings, the resolution must be at least 600 dpi.
Peer Review. All submissions undergo a single-blind, peer-review process to ensure that the material is clinically relevant and concise. A minimum of two reviewers will assess each submision. Strict confidentiality regarding the submitted manuscript is maintained. Based on the reviewers/editors’ comments, manuscripts may be accepted, rejected, or recommended for revision. Reviewers’ comments that are considered constructive will be shared with the author.
Editing and Page Proofs. Articles accepted for publication will be edited for consistency of style, clarity, and correct grammatical construction. Page proofs will be sent to the author prior to publication for approval and may contain author queries that will need to be addressed. The author will be given no more than 48 hours to respond with changes/corrections. The author is responsible for all changes in the manuscript, including those of the copy editor.
Upon publication. The corresponding author of each article receives a PDF of his or her article. Printed reprints are available at a discounted price to the corresponding author. Orders must be for a minimum of 100 copies. Contact Elizabeth Klumpp for pricing at eklumpp (at) matrixmedcom (dot) com.
Innovations in Clinical Neuroscience is indexed with PubMed Central, PsycINFO, CINAHL (Cumulative Index to Nursing and Allied Health Literature®), CINAHL® Plus with Full Text, Scopus, and Embase.
- Original manuscript (double-spaced)
- Cover letter affirming the manuscript’s originality and stating any financial disclosures
- Corresponding author’s name, address, phone number, fax number, and e-mail address on the title page
- References cited in consecutive order in text and conformed to Uniform Requirments style
- Black-and-white or color figures supplied as electronic .jpg or .tif files with a minimum 300dpi
- Professionally executed drawings, algorithms, graphs, charts, etc, with all symbols and abbreviation/ acronyms defined and supplied as electronic .jpg or .tif files with a minimum 300dpi
- Copies of permission letters to reproduce previously published and unpublished material.
Send submissions to:
Elizabeth Klumpp, Executive Editor, Matrix Medical Communications,
(Hard copies are no longer accepted.)
Phone: (866) 325-9907 (toll-free), (484) 266-0702, Fax: (484) 266-0726